Hormone combo may cut breast cancer risk in women with hot flashes
NCT ID NCT04821141
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 30 times
Summary
This study tests whether a combination of bazedoxifene and conjugated estrogens can lower breast cancer risk in women going through menopause who have hot flashes. About 120 women at higher risk for breast cancer will take the drug for 6 months or be placed on a waiting list. Researchers will measure changes in breast density and cell growth to see if the treatment reduces risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Northwestern Medical Center
Chicago, Illinois, 60601, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
University of California San Francisco
San Francisco, California, 94115, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Conditions
Explore the condition pages connected to this study.